Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Crohn's Disease

Interventions

BIOLOGICAL

Adalimumab

Adalimumab pre-filled syringe, administered by subcutaneous injection.

BIOLOGICAL

Placebo for adalimumab

Placebo for adalimumab pre-filled syringe, administered by subcutaneous injection to maintain double-blind.